Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 167

1.

Negative Predictive Biomarkers in Colorectal Cancer: PRESSING Ahead.

Sundar R, Tan IBH, Chee CE.

J Clin Oncol. 2019 Sep 24:JCO1901977. doi: 10.1200/JCO.19.01977. [Epub ahead of print] No abstract available.

PMID:
31550189
2.

Germline Pathogenic Variants in Homologous Recombination and DNA Repair Genes in an Asian Cohort of Young-Onset Colorectal Cancer.

Toh MR, Chiang JB, Chong ST, Chan SH, Ishak NDB, Courtney E, Lee WH, Syed Abdillah Al SMFB, Carson Allen J Jr, Lim KH, Davila S, Tan P, Lim WK, Tan IBH, Ngeow J.

JNCI Cancer Spectr. 2018 Dec 10;2(4):pky054. doi: 10.1093/jncics/pky054. eCollection 2018 Oct.

3.

PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein.

Thura M, Al-Aidaroos AQ, Gupta A, Chee CE, Lee SC, Hui KM, Li J, Guan YK, Yong WP, So J, Chng WJ, Ng CH, Zhou J, Wang LZ, Yuen JSP, Ho HSS, Yi SM, Chiong E, Choo SP, Ngeow J, Ng MCH, Chua C, Yeo ESA, Tan IBH, Sng JXE, Tan NYZ, Thiery JP, Goh BC, Zeng Q.

Nat Commun. 2019 Jun 6;10(1):2484. doi: 10.1038/s41467-019-10127-x.

4.

Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes.

Ragulan C, Eason K, Fontana E, Nyamundanda G, Tarazona N, Patil Y, Poudel P, Lawlor RT, Del Rio M, Koo SL, Tan WS, Sclafani F, Begum R, Teixeira Mendes LS, Martineau P, Scarpa A, Cervantes A, Tan IB, Cunningham D, Sadanandam A.

Sci Rep. 2019 May 21;9(1):7665. doi: 10.1038/s41598-019-43492-0.

5.

The chromatin structuring protein HMGA2 influences human subtelomere stability and cancer chemosensitivity.

Ahmed SM, Ramani PD, Wong SQR, Zhao X, Ivanyi-Nagy R, Leong TC, Chua C, Li Z, Hentze H, Tan IB, Yan J, DasGupta R, Dröge P.

PLoS One. 2019 May 8;14(5):e0215696. doi: 10.1371/journal.pone.0215696. eCollection 2019.

6.

27PDetection of genomic alterations in breast cancer (BC) patients with paired plasma and tumour specimens.

Yap YS, Ho D, Ng RC, Chan CH, Lee AS, Tan IB, Ng SBH.

Ann Oncol. 2019 Feb 1;30(Supplement_1). pii: mdz030.002. doi: 10.1093/annonc/mdz030.002. No abstract available.

PMID:
30810188
7.

Multicenter randomized crossover trial evaluating the provox luna in laryngectomized subjects.

Ratnayake CBB, Fles R, Tan IB, Baijens LWJ, Pilz W, Meeuwis CA, Janssen-van Det PHE, van Son R, Van den Brekel MWM.

Laryngoscope. 2019 Oct;129(10):2354-2360. doi: 10.1002/lary.27839. Epub 2019 Feb 20.

PMID:
30786030
8.

A seven-Gene Signature assay improves prognostic risk stratification of perioperative chemotherapy treated gastroesophageal cancer patients from the MAGIC trial.

Smyth EC, Nyamundanda G, Cunningham D, Fontana E, Ragulan C, Tan IB, Lin SJ, Wotherspoon A, Nankivell M, Fassan M, Lampis A, Hahne JC, Davies AR, Lagergren J, Gossage JA, Maisey N, Green M, Zylstra JL, Allum WH, Langley RE, Tan P, Valeri N, Sadanandam A.

Ann Oncol. 2018 Dec 1;29(12):2356-2362. doi: 10.1093/annonc/mdy407.

9.

Author Correction: Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors.

Li H, Courtois ET, Sengupta D, Tan Y, Chen KH, Goh JJL, Kong SL, Chua C, Hon LK, Tan WS, Wong M, Cima I, Tan MH, Wee LJK, Hillmer AM, Tan IB, Robson P, Prabhakar S.

Nat Genet. 2018 Dec;50(12):1754. doi: 10.1038/s41588-018-0299-1.

PMID:
30420650
10.

Real-Time Tumor Gene Expression Profiling to Direct Gastric Cancer Chemotherapy: Proof-of-Concept "3G" Trial.

Yong WP, Rha SY, Tan IB, Choo SP, Syn NL, Koh V, Tan SH, Asuncion BR, Sundar R, So JB, Shabbir A, Tan CS, Kim HS, Jung M, Chung HC, Ng MCH, Tai DW, Lee MH, Wu J, Yeoh KG, Tan P; Singapore Gastric Cancer Consortium (SGCC).

Clin Cancer Res. 2018 Nov 1;24(21):5272-5281. doi: 10.1158/1078-0432.CCR-18-0193. Epub 2018 Jul 25.

PMID:
30045931
11.

Breast cancer in women with neurofibromatosis type 1 (NF1): a comprehensive case series with molecular insights into its aggressive phenotype.

Yap YS, Munusamy P, Lim C, Chan CHT, Prawira A, Loke SY, Lim SH, Ong KW, Yong WS, Ng SBH, Tan IBH, Callen DF, Lim JCT, Thike AA, Tan PH, Lee ASG.

Breast Cancer Res Treat. 2018 Oct;171(3):719-735. doi: 10.1007/s10549-018-4851-6. Epub 2018 Jun 21.

PMID:
29926297
12.

HER2 positive rates are enriched amongst colorectal cancer brain metastases: a study amongst 1920 consecutive patients.

Tan RYC, Camat MD, Ng M, Lim TH, Lim AST, Lim KH, Tan IBH.

Ann Oncol. 2018 Jul 1;29(7):1598-1603. doi: 10.1093/annonc/mdy156. No abstract available.

PMID:
29868843
13.

Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates.

Simoni Y, Becht E, Fehlings M, Loh CY, Koo SL, Teng KWW, Yeong JPS, Nahar R, Zhang T, Kared H, Duan K, Ang N, Poidinger M, Lee YY, Larbi A, Khng AJ, Tan E, Fu C, Mathew R, Teo M, Lim WT, Toh CK, Ong BH, Koh T, Hillmer AM, Takano A, Lim TKH, Tan EH, Zhai W, Tan DSW, Tan IB, Newell EW.

Nature. 2018 May;557(7706):575-579. doi: 10.1038/s41586-018-0130-2. Epub 2018 May 16.

PMID:
29769722
14.

Human Innate Lymphoid Cell Subsets Possess Tissue-Type Based Heterogeneity in Phenotype and Frequency.

Simoni Y, Fehlings M, Kløverpris HN, McGovern N, Koo SL, Loh CY, Lim S, Kurioka A, Fergusson JR, Tang CL, Kam MH, Dennis K, Lim TKH, Fui ACY, Hoong CW, Chan JKY, Curotto de Lafaille M, Narayanan S, Baig S, Shabeer M, Toh SES, Tan HKK, Anicete R, Tan EH, Takano A, Klenerman P, Leslie A, Tan DSW, Tan IB, Ginhoux F, Newell EW.

Immunity. 2018 May 15;48(5):1060. doi: 10.1016/j.immuni.2018.04.028. No abstract available.

15.

Feasibility of Salvage Selective Neck Dissection after Primary Irradiation of Pharyngeal and Laryngeal Carcinoma.

Mat Lazim N, Abdullah K, Karakullukcu B, Tan IB.

ORL J Otorhinolaryngol Relat Spec. 2018;80(1):10-18. doi: 10.1159/000486371. Epub 2018 Feb 9.

PMID:
29428959
16.

[The role of photodynamic therapy for the treatment of stage I and II carcinoma of the lip].

van Doeveren TEM, Karakullukçu MB, Tan IB, Schreuder WH.

Ned Tijdschr Tandheelkd. 2018 Jan;125(1):43-48. doi: 10.5177/ntvt.2018.01.17102. Dutch.

PMID:
29377969
17.

ConsensusDriver Improves upon Individual Algorithms for Predicting Driver Alterations in Different Cancer Types and Individual Patients.

Bertrand D, Drissler S, Chia BK, Koh JY, Li C, Suphavilai C, Tan IB, Nagarajan N.

Cancer Res. 2018 Jan 1;78(1):290-301. doi: 10.1158/0008-5472.CAN-17-1345. Epub 2017 Dec 19.

18.

Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS.

Yoshino T, Arnold D, Taniguchi H, Pentheroudakis G, Yamazaki K, Xu RH, Kim TW, Ismail F, Tan IB, Yeh KH, Grothey A, Zhang S, Ahn JB, Mastura MY, Chong D, Chen LT, Kopetz S, Eguchi-Nakajima T, Ebi H, Ohtsu A, Cervantes A, Muro K, Tabernero J, Minami H, Ciardiello F, Douillard JY.

Ann Oncol. 2018 Jan 1;29(1):44-70. doi: 10.1093/annonc/mdx738.

PMID:
29155929
19.

VHL Deficiency Drives Enhancer Activation of Oncogenes in Clear Cell Renal Cell Carcinoma.

Yao X, Tan J, Lim KJ, Koh J, Ooi WF, Li Z, Huang D, Xing M, Chan YS, Qu JZ, Tay ST, Wijaya G, Lam YN, Hong JH, Lee-Lim AP, Guan P, Ng MSW, He CZ, Lin JS, Nandi T, Qamra A, Xu C, Myint SS, Davies JOJ, Goh JY, Loh G, Tan BC, Rozen SG, Yu Q, Tan IBH, Cheng CWS, Li S, Chang KTE, Tan PH, Silver DL, Lezhava A, Steger G, Hughes JR, Teh BT, Tan P.

Cancer Discov. 2017 Nov;7(11):1284-1305. doi: 10.1158/2159-8290.CD-17-0375. Epub 2017 Sep 11.

20.

Preoperative Prognostic Factors After Liver Resection for Non-Colorectal, Non-Neuroendocrine Liver Metastases and Validation of the Adam Score in an Asian Population.

Sim DPY, Goh BKP, Lee SY, Chan CY, Tan IBH, Cheow PC, Jeyaraj P, Chow PKH, Ooi LLPJ, Chung AYF.

World J Surg. 2018 Apr;42(4):1073-1084. doi: 10.1007/s00268-017-4208-z.

PMID:
28875334
21.

Phenotype-driven precision oncology as a guide for clinical decisions one patient at a time.

Chia S, Low JL, Zhang X, Kwang XL, Chong FT, Sharma A, Bertrand D, Toh SY, Leong HS, Thangavelu MT, Hwang JSG, Lim KH, Skanthakumar T, Tan HK, Su Y, Hui Choo S, Hentze H, Tan IBH, Lezhava A, Tan P, Tan DSW, Periyasamy G, Koh JLY, Gopalakrishna Iyer N, DasGupta R.

Nat Commun. 2017 Sep 5;8(1):435. doi: 10.1038/s41467-017-00451-5.

22.

Adjuvant photodynamic therapy in head and neck cancer after tumor-positive resection margins.

van Doeveren TEM, Karakullukçu MB, van Veen RLP, Lopez-Yurda M, Schreuder WH, Tan IB.

Laryngoscope. 2018 Mar;128(3):657-663. doi: 10.1002/lary.26792. Epub 2017 Aug 8.

PMID:
28786113
23.

A formalin-fixed paraffin-embedded (FFPE)-based prognostic signature to predict metastasis in clinically low risk stage I/II microsatellite stable colorectal cancer.

Low YS, Blöcker C, McPherson JR, Tang SA, Cheng YY, Wong JYS, Chua C, Lim TKH, Tang CL, Chew MH, Tan P, Tan IB, Rozen SG, Cheah PY.

Cancer Lett. 2017 Sep 10;403:13-20. doi: 10.1016/j.canlet.2017.05.031. Epub 2017 Jun 15.

PMID:
28624625
24.

Evaluation of Long-Term Outcomes of Microsatellite Instability Status in an Asian Cohort of Sporadic Colorectal Cancers.

Tan WJ, Hamzah JL, Acharyya S, Foo FJ, Lim KH, Tan IBH, Tang CL, Chew MH.

J Gastrointest Cancer. 2018 Sep;49(3):311-318. doi: 10.1007/s12029-017-9953-6.

PMID:
28550452
25.

The role of Indonesian patients' health behaviors in delaying the diagnosis of nasopharyngeal carcinoma.

Fles R, Bos ACRK, Supriyati, Rachmawati D, Waliyanti E, Tan IB, Haryana SM, Schmidt MK, Dewi FST.

BMC Public Health. 2017 May 25;17(1):510. doi: 10.1186/s12889-017-4429-y.

26.

Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors.

Li H, Courtois ET, Sengupta D, Tan Y, Chen KH, Goh JJL, Kong SL, Chua C, Hon LK, Tan WS, Wong M, Choi PJ, Wee LJK, Hillmer AM, Tan IB, Robson P, Prabhakar S.

Nat Genet. 2017 May;49(5):708-718. doi: 10.1038/ng.3818. Epub 2017 Mar 20. Erratum in: Nat Genet. 2018 Dec;50(12):1754.

PMID:
28319088
27.

Multiregion ultra-deep sequencing reveals early intermixing and variable levels of intratumoral heterogeneity in colorectal cancer.

Suzuki Y, Ng SB, Chua C, Leow WQ, Chng J, Liu SY, Ramnarayanan K, Gan A, Ho DL, Ten R, Su Y, Lezhava A, Lai JH, Koh D, Lim KH, Tan P, Rozen SG, Tan IB.

Mol Oncol. 2017 Feb;11(2):124-139. doi: 10.1002/1878-0261.12012. Epub 2016 Oct 20.

28.

Individualised multiplexed circulating tumour DNA assays for monitoring of tumour presence in patients after colorectal cancer surgery.

Ng SB, Chua C, Ng M, Gan A, Poon PS, Teo M, Fu C, Leow WQ, Lim KH, Chung A, Koo SL, Choo SP, Ho D, Rozen S, Tan P, Wong M, Burkholder WF, Tan IB.

Sci Rep. 2017 Jan 19;7:40737. doi: 10.1038/srep40737.

29.

Human Innate Lymphoid Cell Subsets Possess Tissue-Type Based Heterogeneity in Phenotype and Frequency.

Simoni Y, Fehlings M, Kløverpris HN, McGovern N, Koo SL, Loh CY, Lim S, Kurioka A, Fergusson JR, Tang CL, Kam MH, Dennis K, Lim TKH, Fui ACY, Hoong CW, Chan JKY, Curotto de Lafaille M, Narayanan S, Baig S, Shabeer M, Toh SES, Tan HKK, Anicete R, Tan EH, Takano A, Klenerman P, Leslie A, Tan DSW, Tan IB, Ginhoux F, Newell EW.

Immunity. 2017 Jan 17;46(1):148-161. doi: 10.1016/j.immuni.2016.11.005. Epub 2016 Dec 13. Erratum in: Immunity. 2018 May 15;48(5):1060.

30.

Frequent Coamplification of Receptor Tyrosine Kinase and Downstream Signaling Genes in Japanese Primary Gastric Cancer and Conversion in Matched Lymph Node Metastasis.

Silva ANS, Coffa J, Menon V, Hewitt LC, Das K, Miyagi Y, Bottomley D, Slaney H, Aoyama T, Mueller W, Arai T, Tan IB, Deng N, Chan XB, Tan P, Tsuburaya A, Sakamaki K, Hayden JD, Yoshikawa T, Zondervan I, Savola S, Grabsch HI.

Ann Surg. 2018 Jan;267(1):114-121. doi: 10.1097/SLA.0000000000002042.

31.

Prognostic significance of KIT exon 11 deletion mutation in intermediate-risk gastrointestinal stromal tumor.

Quek R, Farid M, Kanjanapan Y, Lim C, Tan IB, Kesavan S, Lim TKH, Oon LL, Goh BK, Chan WH, Teo M, Chung AY, Ong HS, Wong WK, Tan P, Yip D.

Asia Pac J Clin Oncol. 2017 Jun;13(3):115-124. doi: 10.1111/ajco.12603. Epub 2016 Oct 17.

PMID:
27753268
32.

A Randomized Phase II Study of FOLFOX With or Without the MET Inhibitor Onartuzumab in Advanced Adenocarcinoma of the Stomach and Gastroesophageal Junction.

Shah MA, Cho JY, Tan IB, Tebbutt NC, Yen CJ, Kang A, Shames DS, Bu L, Kang YK.

Oncologist. 2016 Sep;21(9):1085-90. doi: 10.1634/theoncologist.2016-0038. Epub 2016 Jul 8.

33.

Tumor-derived circulating endothelial cell clusters in colorectal cancer.

Cima I, Kong SL, Sengupta D, Tan IB, Phyo WM, Lee D, Hu M, Iliescu C, Alexander I, Goh WL, Rahmani M, Suhaimi NA, Vo JH, Tai JA, Tan JH, Chua C, Ten R, Lim WJ, Chew MH, Hauser CA, van Dam RM, Lim WY, Prabhakar S, Lim B, Koh PK, Robson P, Ying JY, Hillmer AM, Tan MH.

Sci Transl Med. 2016 Jun 29;8(345):345ra89. doi: 10.1126/scitranslmed.aad7369.

PMID:
27358499
34.

Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia.

Fukawa T, Yan-Jiang BC, Min-Wen JC, Jun-Hao ET, Huang D, Qian CN, Ong P, Li Z, Chen S, Mak SY, Lim WJ, Kanayama HO, Mohan RE, Wang RR, Lai JH, Chua C, Ong HS, Tan KK, Ho YS, Tan IB, Teh BT, Shyh-Chang N.

Nat Med. 2016 Jun;22(6):666-71. doi: 10.1038/nm.4093. Epub 2016 May 2.

PMID:
27135739
35.

Safety and efficacy of aflibercept in combination with fluorouracil, leucovorin and irinotecan in the treatment of Asian patients with metastatic colorectal cancer.

Chong DQ, Manalo M, Imperial M, Teo P, Yong G, Ng M, Tan IB, Choo SP, Chua C.

Asia Pac J Clin Oncol. 2016 Sep;12(3):275-83. doi: 10.1111/ajco.12496. Epub 2016 Apr 14.

PMID:
27075236
36.

The Impact of the Overall Radiotherapy Time on Clinical Outcome of Patients with Nasopharyngeal Carcinoma; A Retrospective Study.

Stoker SD, Fles R, Herdini C, Rijntjes FJ, Tjokronagoro M, Dwidanarti SR, Sikorska K, Leemans CR, Schmidt MK, Al-Mamgani A, Wildeman MA, Haryana SM, Indrasari SR, Tan IB.

PLoS One. 2016 Mar 31;11(3):e0151899. doi: 10.1371/journal.pone.0151899. eCollection 2016.

37.

Technical Validation of a Next-Generation Sequencing Assay for Detecting Actionable Mutations in Patients with Gastrointestinal Cancer.

Wang SR, Malik S, Tan IB, Chan YS, Hoi Q, Ow JL, He CZ, Ching CE, Poh DYS, Seah HM, Cheung KHT, Perumal D, Devasia AG, Pan L, Ang S, Lee SE, Ten R, Chua C, Tan DSW, Qu JZZ, Bylstra YM, Lim L, Lezhava A, Ng PC, Wong CW, Lim T, Tan P.

J Mol Diagn. 2016 May;18(3):416-424. doi: 10.1016/j.jmoldx.2016.01.006. Epub 2016 Mar 9.

PMID:
26970585
38.

Effectiveness of a multicentre nasopharyngeal carcinoma awareness programme in Indonesia.

Fles R, Indrasari SR, Herdini C, Martini S, Isfandiari A, Romdhoni AC, Adham M, Mayangsari ID, van Werkhoven E, Wildeman MA, Hariwiyanto B, Hermani B, Kentjono WA, Haryana SM, Schmidt MK, Tan IB.

BMJ Open. 2016 Mar 1;6(3):e008571. doi: 10.1136/bmjopen-2015-008571.

39.

Melanoma associated antigen (MAGE)-A3 promotes cell proliferation and chemotherapeutic drug resistance in gastric cancer.

Xie C, Subhash VV, Datta A, Liem N, Tan SH, Yeo MS, Tan WL, Koh V, Yan FL, Wong FY, Wong WK, So J, Tan IB, Padmanabhan N, Yap CT, Tan P, Goh LK, Yong WP.

Cell Oncol (Dordr). 2016 Apr;39(2):175-86. doi: 10.1007/s13402-015-0261-5. Epub 2016 Feb 11.

PMID:
26868260
40.

Irradiation of localized squamous cell carcinoma of the nasal vestibule.

Vanneste BG, Lopez-Yurda M, Tan IB, Balm AJ, Borst GR, Rasch CR.

Head Neck. 2016 Apr;38 Suppl 1:E1870-5. doi: 10.1002/hed.24337. Epub 2015 Dec 26.

PMID:
26706779
41.

Palliative surgical intervention in metastatic colorectal carcinoma: a prospective analysis of quality of life.

Tan WJ, Chew MH, Tan IB, Law JH, Zhao R, Acharyya S, Mao YL, Fernandez LG, Loi CT, Tang CL.

Colorectal Dis. 2016 Apr;18(4):357-63. doi: 10.1111/codi.13142.

PMID:
26437936
42.

SETD2 histone modifier loss in aggressive GI stromal tumours.

Huang KK, McPherson JR, Tay ST, Das K, Tan IB, Ng CC, Chia NY, Zhang SL, Myint SS, Hu L, Rajasegaran V, Huang D, Loh JL, Gan A, Sairi AN, Sam XX, Dominguez LT, Lee M, Soo KC, Ooi LL, Ong HS, Chung A, Chow PK, Wong WK, Selvarajan S, Ong CK, Lim KH, Nandi T, Rozen S, Teh BT, Quek R, Tan P.

Gut. 2016 Dec;65(12):1960-1972. doi: 10.1136/gutjnl-2015-309482. Epub 2015 Sep 3.

PMID:
26338826
43.

Assessment of Web-Based Consumer Reviews as a Resource for Drug Performance.

Adusumalli S, Lee H, Hoi Q, Koo SL, Tan IB, Ng PC.

J Med Internet Res. 2015 Aug 28;17(8):e211. doi: 10.2196/jmir.4396.

44.

Phase II study of trastuzumab in combination with S-1 and cisplatin in the first-line treatment of human epidermal growth factor receptor HER2-positive advanced gastric cancer.

Chua C, Tan IB, Yamada Y, Rha SY, Yong WP, Ong WS, Tham CK, Ng M, Tai DW, Iwasa S, Lim HY, Choo SP.

Cancer Chemother Pharmacol. 2015 Aug;76(2):397-408. doi: 10.1007/s00280-015-2811-y. Epub 2015 Jun 24.

PMID:
26099969
45.

The use of photodynamic therapy as adjuvant therapy to surgery in recurrent malignant tumors of the paranasal sinuses.

Caesar L, van Doeveren TE, Tan IB, Dilci A, van Veen RL, Karakullukcu B.

Photodiagnosis Photodyn Ther. 2015 Sep;12(3):414-21. doi: 10.1016/j.pdpdt.2015.06.001. Epub 2015 Jun 10.

PMID:
26072296
46.

Can Epstein-Barr virus DNA load in nasopharyngeal brushings or whole blood predict recurrent nasopharyngeal carcinoma in a non-endemic region? A prospective nationwide study of the Dutch Head and Neck Oncology Cooperative Group.

Stoker SD, Wildeman MA, Novalic Z, Fles R, van der Noort V, de Bree R, Braunius WW, van den Broek GB, Kreike B, Kross KW, Juwana H, Ramayanti O, Verkuijlen SA, de Boer JP, Greijer AE, Middeldorp JM, Tan IB.

Eur Arch Otorhinolaryngol. 2016 Jun;273(6):1557-67. doi: 10.1007/s00405-015-3620-y. Epub 2015 May 1.

PMID:
25929413
47.

Addressing the needs of colorectal cancer survivors: current strategies and future directions.

Wong EY, Chua C, Beh SY, Koh D, Chong D, Tan IB.

Expert Rev Anticancer Ther. 2015 Jun;15(6):639-48. doi: 10.1586/14737140.2015.1038248. Epub 2015 Apr 30. Review.

PMID:
25927672
48.

Epstein-Barr virus-targeted therapy in nasopharyngeal carcinoma.

Stoker SD, Novalić Z, Wildeman MA, Huitema AD, Verkuijlen SA, Juwana H, Greijer AE, Tan IB, Middeldorp JM, de Boer JP.

J Cancer Res Clin Oncol. 2015 Oct;141(10):1845-57. doi: 10.1007/s00432-015-1969-3. Epub 2015 Apr 29.

PMID:
25920375
49.

Photodynamic therapy as salvage therapy for patients with nasopharyngeal carcinoma experiencing local failures following definitive radiotherapy.

Stoker SD, Indrasari SR, Herdini C, Hariwiyanto B, Karakullukcu B, Dhamiyati W, Widayati K, Romdhoni AC, Fles R, Haryana SM, Wildeman MA, Tan IB.

Photodiagnosis Photodyn Ther. 2015 Sep;12(3):519-25. doi: 10.1016/j.pdpdt.2015.04.005. Epub 2015 Apr 23.

PMID:
25917042
50.

Metronomic vinorelbine (oral) in combination with sorafenib in advanced non-small cell lung cancer.

Tan EH, Tan DS, Li WY, Haaland B, Ang MK, Chau NM, Toh CK, Tan IB, Koh TS, Thng CH, Chowbay B, Hui KM, Lim WT, Ng QS.

Lung Cancer. 2015 Jun;88(3):289-96. doi: 10.1016/j.lungcan.2015.04.001. Epub 2015 Apr 13.

PMID:
25896396

Supplemental Content

Support Center